The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Head Lice Infestation Drug-Global Market Insights and Sales Trends 2025
Synopsis
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
The global Head Lice Infestation Drug market size is expected to reach US$ 495.6 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Head Lice Infestation Drug in various end use industries. The expanding demands from the Children and Adult, are propelling Head Lice Infestation Drug market. Lotion, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Creams segment is estimated at % CAGR for the next seven-year period.
Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Head Lice Infestation Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Head Lice Infestation Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Head Lice Infestation Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Head Lice Infestation Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Head Lice Infestation Drug covered in this report include Bayer, Omega Pharma, Thornton and Ross, Prestige Brands, Perrigo, Actavis, Reckitt Benckier, Tyratech and Shionogi, etc.
The global Head Lice Infestation Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO
Global Head Lice Infestation Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Head Lice Infestation Drug market, Segment by Type:
Lotion
Creams
Shampoo
Other
Global Head Lice Infestation Drug market, by Application
Children
Adult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Head Lice Infestation Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Head Lice Infestation Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
The global Head Lice Infestation Drug market size is expected to reach US$ 495.6 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Head Lice Infestation Drug in various end use industries. The expanding demands from the Children and Adult, are propelling Head Lice Infestation Drug market. Lotion, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Creams segment is estimated at % CAGR for the next seven-year period.
Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Head Lice Infestation Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Head Lice Infestation Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Head Lice Infestation Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Head Lice Infestation Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Head Lice Infestation Drug covered in this report include Bayer, Omega Pharma, Thornton and Ross, Prestige Brands, Perrigo, Actavis, Reckitt Benckier, Tyratech and Shionogi, etc.
The global Head Lice Infestation Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO
Global Head Lice Infestation Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Head Lice Infestation Drug market, Segment by Type:
Lotion
Creams
Shampoo
Other
Global Head Lice Infestation Drug market, by Application
Children
Adult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Head Lice Infestation Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Head Lice Infestation Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Head Lice Infestation Drug Market Overview
1.1 Head Lice Infestation Drug Product Overview
1.2 Head Lice Infestation Drug Market Segment by Type
1.2.1 Lotion
1.2.2 Creams
1.2.3 Shampoo
1.2.4 Other
1.3 Global Head Lice Infestation Drug Market Size by Type
1.3.1 Global Head Lice Infestation Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Head Lice Infestation Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Head Lice Infestation Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Head Lice Infestation Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Head Lice Infestation Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Head Lice Infestation Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Head Lice Infestation Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Head Lice Infestation Drug Sales Breakdown by Type (2018-2023)
2 Global Head Lice Infestation Drug Market Competition by Company
2.1 Global Top Players by Head Lice Infestation Drug Sales (2018-2023)
2.2 Global Top Players by Head Lice Infestation Drug Revenue (2018-2023)
2.3 Global Top Players by Head Lice Infestation Drug Price (2018-2023)
2.4 Global Top Manufacturers Head Lice Infestation Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Head Lice Infestation Drug Market Competitive Situation and Trends
2.5.1 Head Lice Infestation Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Head Lice Infestation Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Head Lice Infestation Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Head Lice Infestation Drug Market
2.8 Key Manufacturers Head Lice Infestation Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Head Lice Infestation Drug Status and Outlook by Region
3.1 Global Head Lice Infestation Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Head Lice Infestation Drug Historic Market Size by Region
3.2.1 Global Head Lice Infestation Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Head Lice Infestation Drug Sales in Value by Region (2018-2023)
3.2.3 Global Head Lice Infestation Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Head Lice Infestation Drug Forecasted Market Size by Region
3.3.1 Global Head Lice Infestation Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Head Lice Infestation Drug Sales in Value by Region (2024-2029)
3.3.3 Global Head Lice Infestation Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Head Lice Infestation Drug by Application
4.1 Head Lice Infestation Drug Market Segment by Application
4.1.1 Children
4.1.2 Adult
4.2 Global Head Lice Infestation Drug Market Size by Application
4.2.1 Global Head Lice Infestation Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Head Lice Infestation Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Head Lice Infestation Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Head Lice Infestation Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Head Lice Infestation Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Head Lice Infestation Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Head Lice Infestation Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Head Lice Infestation Drug Sales Breakdown by Application (2018-2023)
5 North America Head Lice Infestation Drug by Country
5.1 North America Head Lice Infestation Drug Historic Market Size by Country
5.1.1 North America Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Head Lice Infestation Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Head Lice Infestation Drug Sales in Value by Country (2018-2023)
5.2 North America Head Lice Infestation Drug Forecasted Market Size by Country
5.2.1 North America Head Lice Infestation Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Head Lice Infestation Drug Sales in Value by Country (2024-2029)
6 Europe Head Lice Infestation Drug by Country
6.1 Europe Head Lice Infestation Drug Historic Market Size by Country
6.1.1 Europe Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Head Lice Infestation Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Head Lice Infestation Drug Sales in Value by Country (2018-2023)
6.2 Europe Head Lice Infestation Drug Forecasted Market Size by Country
6.2.1 Europe Head Lice Infestation Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Head Lice Infestation Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Head Lice Infestation Drug by Region
7.1 Asia-Pacific Head Lice Infestation Drug Historic Market Size by Region
7.1.1 Asia-Pacific Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Head Lice Infestation Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Head Lice Infestation Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Head Lice Infestation Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Head Lice Infestation Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Head Lice Infestation Drug Sales in Value by Region (2024-2029)
8 Latin America Head Lice Infestation Drug by Country
8.1 Latin America Head Lice Infestation Drug Historic Market Size by Country
8.1.1 Latin America Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Head Lice Infestation Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Head Lice Infestation Drug Sales in Value by Country (2018-2023)
8.2 Latin America Head Lice Infestation Drug Forecasted Market Size by Country
8.2.1 Latin America Head Lice Infestation Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Head Lice Infestation Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Head Lice Infestation Drug by Country
9.1 Middle East and Africa Head Lice Infestation Drug Historic Market Size by Country
9.1.1 Middle East and Africa Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Head Lice Infestation Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Head Lice Infestation Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Head Lice Infestation Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Head Lice Infestation Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Head Lice Infestation Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Head Lice Infestation Drug Products Offered
10.1.5 Bayer Recent Development
10.2 Omega Pharma
10.2.1 Omega Pharma Company Information
10.2.2 Omega Pharma Introduction and Business Overview
10.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Omega Pharma Head Lice Infestation Drug Products Offered
10.2.5 Omega Pharma Recent Development
10.3 Thornton and Ross
10.3.1 Thornton and Ross Company Information
10.3.2 Thornton and Ross Introduction and Business Overview
10.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Thornton and Ross Head Lice Infestation Drug Products Offered
10.3.5 Thornton and Ross Recent Development
10.4 Prestige Brands
10.4.1 Prestige Brands Company Information
10.4.2 Prestige Brands Introduction and Business Overview
10.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Prestige Brands Head Lice Infestation Drug Products Offered
10.4.5 Prestige Brands Recent Development
10.5 Perrigo
10.5.1 Perrigo Company Information
10.5.2 Perrigo Introduction and Business Overview
10.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Perrigo Head Lice Infestation Drug Products Offered
10.5.5 Perrigo Recent Development
10.6 Actavis
10.6.1 Actavis Company Information
10.6.2 Actavis Introduction and Business Overview
10.6.3 Actavis Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Actavis Head Lice Infestation Drug Products Offered
10.6.5 Actavis Recent Development
10.7 Reckitt Benckier
10.7.1 Reckitt Benckier Company Information
10.7.2 Reckitt Benckier Introduction and Business Overview
10.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Reckitt Benckier Head Lice Infestation Drug Products Offered
10.7.5 Reckitt Benckier Recent Development
10.8 Tyratech
10.8.1 Tyratech Company Information
10.8.2 Tyratech Introduction and Business Overview
10.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Tyratech Head Lice Infestation Drug Products Offered
10.8.5 Tyratech Recent Development
10.9 Shionogi
10.9.1 Shionogi Company Information
10.9.2 Shionogi Introduction and Business Overview
10.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shionogi Head Lice Infestation Drug Products Offered
10.9.5 Shionogi Recent Development
10.10 TecLabs
10.10.1 TecLabs Company Information
10.10.2 TecLabs Introduction and Business Overview
10.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 TecLabs Head Lice Infestation Drug Products Offered
10.10.5 TecLabs Recent Development
10.11 Arborpharma
10.11.1 Arborpharma Company Information
10.11.2 Arborpharma Introduction and Business Overview
10.11.3 Arborpharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Arborpharma Head Lice Infestation Drug Products Offered
10.11.5 Arborpharma Recent Development
10.12 Major Pharmaceuticals
10.12.1 Major Pharmaceuticals Company Information
10.12.2 Major Pharmaceuticals Introduction and Business Overview
10.12.3 Major Pharmaceuticals Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Major Pharmaceuticals Head Lice Infestation Drug Products Offered
10.12.5 Major Pharmaceuticals Recent Development
10.13 Logic Products
10.13.1 Logic Products Company Information
10.13.2 Logic Products Introduction and Business Overview
10.13.3 Logic Products Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Logic Products Head Lice Infestation Drug Products Offered
10.13.5 Logic Products Recent Development
10.14 Tianren
10.14.1 Tianren Company Information
10.14.2 Tianren Introduction and Business Overview
10.14.3 Tianren Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Tianren Head Lice Infestation Drug Products Offered
10.14.5 Tianren Recent Development
10.15 ParaPRO
10.15.1 ParaPRO Company Information
10.15.2 ParaPRO Introduction and Business Overview
10.15.3 ParaPRO Head Lice Infestation Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 ParaPRO Head Lice Infestation Drug Products Offered
10.15.5 ParaPRO Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Head Lice Infestation Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Head Lice Infestation Drug Industrial Chain Analysis
11.4 Head Lice Infestation Drug Market Dynamics
11.4.1 Head Lice Infestation Drug Industry Trends
11.4.2 Head Lice Infestation Drug Market Drivers
11.4.3 Head Lice Infestation Drug Market Challenges
11.4.4 Head Lice Infestation Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Head Lice Infestation Drug Distributors
12.3 Head Lice Infestation Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
